SCHEMBL7991406

SCHEMBL7991406

O=c1nc(-c2ccccc2)[nH]c2ncn(Cc3ccc(Cl)cc3)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 2/20 0.49
PARN O95453 1/20 0.49
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
MAPK1 P28482 2/20 0.42
HTT P42858 1/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PNP P00491 1/20 0.41
ALDH1A1 P00352 2/20 0.41
MDM4 O15151 2/20 0.41
TP53 P04637 2/20 0.41
MDM2 Q00987 2/20 0.41
CXCR2 P25025 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
TNKS O95271 1/20 0.40
GUSB P08236 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984461 0.95 CNOT7 (0.52) CNOT7PARNSMN1; SMN2KMT2APNP
SCHEMBL7975271 0.93 CNOT7 (0.56) CNOT7PARNSMN1; SMN2KMT2APNP
SCHEMBL7986522 0.89 CNOT7 (0.48) CNOT7PARNCYP11B1CYP11B2SMN1; SMN2
SCHEMBL7984720 0.89 CNOT7 (0.48) CNOT7PARNCYP11B1CYP11B2SMN1; SMN2
SCHEMBL7988669 0.89 PARN (0.48) CNOT7PARNSMN1; SMN2MAPK1HTT
SCHEMBL7974015 0.87 PARN (0.49) CNOT7PARNSMN1; SMN2MAPK1HTT
SCHEMBL7974492 0.86 ABCC8 (0.47) CNOT7PARNSMN1; SMN2HTTMEN1
SCHEMBL7985707 0.86 CYP11B2 (0.47) CNOT7PARNCYP11B1CYP11B2HTT
SCHEMBL7987953 0.86 PDE2A (0.46) CNOT7PARNSMN1; SMN2MEN1KMT2A
SCHEMBL7974444 0.86 CNOT7 (0.52) CNOT7PARNSMN1; SMN2KMT2APNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed